BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Assimakopoulos SF, Scopa CD, Nikolopoulou VN, Vagianos CE. Pleiotropic effects of bombesin and neurotensin on intestinal mucosa: Not just trefoil peptides. World J Gastroenterol 2008; 14(22): 3602-3603 [PMID: 18567096 DOI: 10.3748/wjg.14.3602] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Deiana S, Gabbani T, Bagnoli S, Annese V. Emerging drug for diarrhea predominant irritable bowel syndrome. Expert Opin Emerg Drugs 2015;20:247-61. [PMID: 25732091 DOI: 10.1517/14728214.2015.1013935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Pereira da Silva L, Miguel Neves B, Moura L, Cruz MT, Carvalho E. Neurotensin decreases the proinflammatory status of human skin fibroblasts and increases epidermal growth factor expression. Int J Inflam 2014;2014:248240. [PMID: 25180119 DOI: 10.1155/2014/248240] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
3 da Silva L, Neves BM, Moura L, Cruz MT, Carvalho E. Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochim Biophys Acta 2011;1813:1863-71. [PMID: 21767580 DOI: 10.1016/j.bbamcr.2011.06.018] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
4 Margolis KG, Gershon MD. Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol. 2009;25:503-511. [PMID: 19816171 DOI: 10.1097/mog.0b013e328331b69e] [Cited by in Crossref: 68] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]